Astellas Advances Oncology Strategy with US$1.4 B Ganymed Purchase
By Jawala Prasad
Pharma Deals Review: Vol 2016 Issue 11 (Table of Contents)
Published: 10 Nov-2016
DOI: 10.3833/pdr.v2016.i11.2206 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
In line with its aim to create a competitive pipeline in oncology, Astellas Pharma has signed a deal worth up to US$1...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS